There are several key criteria that determine whether a Clinical Trial Agreement (CTA) successfully achieves this. This section of the agreement is often overlooked by sponsors, CROs, and sites. The purpose of this section is to explicitly indicate the description of the research project. You would like to document the overall purpose of the agreement in this section. In the United States, the Sunshine Act strengthens the verification of payments to health organizations and health professionals. The project description contains the details necessary for the nature of the agreement. While an insurance clause obliging the site and/or PI3 to take out professional liability insurance during the clinical trial and for an appropriate period thereafter, should be included in all CTAs; The website or IP may not have the appropriate insurance or it may not have on-site insurance.